NVIDIA Corporation - Uncertainty over China; but demand still robust

27 Nov 2023
  • 3Q24 results exceeded expectations. Revenue beat NVDA’s own guidance by 13%, with PATMI spiking 13x YoY. 9M24 revenue/PATMI was at 75%/80% of our FY24e forecasts.
  • Data Centre (DC) revenue grew almost 4x YoY, driven by: 1) Enterprises and nations inferencing large language models (LLMs); 2) Cloud Service Providers (CSPs) expanding into new markets; 3) 5x YoY growth in demand for InfiniBand.
  • Upbeat 4Q24e revenue guidance of US$20bn implies 231% YoY growth, and US$59bn for FY24e. US export controls to China remain an uncertainty, with revenue from China expected to decrease substantially in 4Q24e.
  • We raised our FY24e revenue/PATMI by 13%/27% for the stronger demand of Data Centre products. NVDA dominates AI GPUs that is growing ~4x YoY. Demand is driven by a global shift to accelerated computing for generative AI applications, and inferencing LLMs. We maintain a BUY rating with a raised target price of US$685 (prev. US$645). Our WACC/g is unchanged (6.8%/4.5%).

 

 

The Positives

+ Demand for Data Centre GPUs still outpacing supply. DC growth continues to be driven by: 1) Increased investments from consumer internet companies into inferencing LLMs and generative AI applications; 2) Hyperscale CSPs expanding into new market opportunities; 3) 5x YoY increase in demand for InfiniBand (Networking >US$10bn annual run-rate). To meet the demand, NVDA has been increasing supply QoQ this year, and expects to continue this into FY25e. DC revenue spiked 280%/41% YoY/QoQ as a result. We expect near-term demand to remain strong given overflowing customer commitments.

+ 4Q24e revenue guidance implies 231% YoY growth. NVDA guided US$20bn (+/- 2%) in revenue for 4Q24e, implying further acceleration in revenue growth – above consensus estimates of US$18bn. Most of the growth is expected to be driven by DC demand, and takes into account a significant drop in revenue contribution from China due to US export controls. Taking this guidance, our FY24e revenue is raised 13% to US$59bn, implying a 118% YoY growth. 4Q24e gross margins are also expected to increase sequentially to 74.5% due to a favourable product mix as demand for higher margin DC products continue to expand, with NVDA ending FY24e with a 72% gross margin, 1500bps higher than FY23.

 

The Negative

– Export controls expected to impact China revenue in 4Q24e. US government export control regulations to China are expected to impact revenue from China moving forward, with limited visibility on its long term impact. NVDA is working on regulation-compliant products for the affected markets, although the contribution from these products is not expected to be meaningful in the near term. China revenue represents 20-25% of NVDA’s total revenue.

 

Outlook

Guidance: NVDA guided to 4Q24e revenue of US$20bn (+/- 2%), implying a further acceleration in YoY growth as demand for its DC products is extremely robust. NVDA also guided a gross margin of 74.5%, a sequential 50bps expansion due to a more favourable shift in mix to higher-margin DC products.

About the author

Jonathan Woo
Research Analyst
PSR

Jonathan covers the US technology sector focusing on internet companies. Formerly a national and professional athlete, he graduated from the University of Oregon with a Bachelor’s Degree in Social Sciences.

Latest Reports

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com